Biosimilar 对比 DRUGDOCS 的使用情况和统计数据

Biologic drugs offer important treatment options for patients suffering from auto-immune disorders such as rheumatoid arthritis and for common cancers including breast and colon. Biosimilar and interchangeable products, which can loosely be thought of as ‘generic’ biologics, are important for promoting competition and driving down costs. The FDA maintains a list of approved biosimilars in the Purple Book. The Biosimilar iOS app provides a handy reference to the Purple Book as well as important information related to prescribing and dispensing for clinicians and pharmacists navigating this complex area of drug therapeutics. ** Disclaimer ** - non-medical users should ask for a doctor’s advice in addition to using this app and before making any medical decisions.
  • Apple 应用商店
  • 付费
  • 医疗

商店排名

- -

DRUGDOCS® provides health professionals with current, evidence-based information on the drugs they prescribe with direct access to publications.
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

Biosimilar与DRUGDOCS排名比较

对比 Biosimilar 与 DRUGDOCS 在过去 28 天内的排名趋势

BiosimilarBiosimilar#132

排名

Biosimilar 对比 DRUGDOCS 的排名,按国家/地区比较

对比 Biosimilar 与 DRUGDOCS 在过去 28 天内的排名趋势

所有品类

没有可用的数据

医疗

应用
热门国家/地区
排名
#132
- -
- -

通过免费试用版比较任何网站

开始使用
Biosimilar VS.
DRUGDOCS

十二月 19, 2024